We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600143:SSEKingfa Sci. & Tech. Co., Ltd. Class A Analysis

Data as of 2026-07-15 - not real-time

CN¥14.31

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading below its 20‑day and 50‑day moving averages and markedly under the 200‑day average, signaling a bearish bias. RSI sits in the high‑30s, hinting at modest oversold pressure but not a clear reversal. MACD shows a bearish histogram and the signal line is below the MACD line, reinforcing downside momentum. Price is hovering just above the identified support around 13.9 CNY, while resistance near 17.4 CNY remains out of reach, and recent volume trends are rising, suggesting that sellers are still in control. Volatility is elevated at roughly 56% over the past month, and beta is low, indicating limited market‑wide correlation but heightened stock‑specific swings.
Fundamental outlook: Revenue growth is essentially flat and margins are thin, with gross margins barely above 13% and a net profit margin under 2%. Return on equity is low, and the balance sheet shows a debt‑to‑equity ratio exceeding 120%, implying substantial leverage. The discounted cash flow model places intrinsic value near 10 CNY, well below the current price of about 14.3 CNY, pointing to an overvalued market price. Nonetheless, the company pays a modest 1.4% dividend with a low payout ratio, and cash flow generation remains positive, supporting dividend sustainability. Market sentiment is in an “Extreme Greed” phase, which may be inflating the price further.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (price below key moving averages, negative MACD)
  • Current price exceeds DCF-derived fair value
  • High leverage amplifies downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Modest dividend yield with sustainable payout
  • Forward earnings estimate shows improvement
  • Debt level remains a concern, limiting upside

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Long‑term demand for specialty chemicals and engineered plastics
  • Potential for operational improvements to boost margins
  • Persistent valuation gap and high leverage constrain long‑run upside

Key Metrics & Analysis

Financial Health

Revenue Growth-0.50%
Profit Margin1.85%
P/E Ratio31.1
ROE3.98%
ROA2.98%
Debt/Equity120.80
P/B Ratio1.9
Op. Cash FlowCN¥7.1B
Free Cash FlowCN¥3.6B

Technical Analysis

TrendBearish
RSI37.7
SupportCN¥13.90
ResistanceCN¥17.40
MA 20CN¥15.75
MA 50CN¥16.62
MA 200CN¥18.22
MACDBearish
VolumeIncreasing
Fear & Greed Index91.96

Valuation

Fair ValueCN¥9.97
GradeOvervalued
TypeValue
Dividend Yield1.40%

Risk Assessment

Beta0.37
Volatility56.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.